Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

MOAT
VanEck Vectors Morningstar Wide Moat ETF

  • Fund Description

    VanEck Vectors® Morningstar Wide Moat ETF (MOAT®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Morningstar® Wide Moat Focus IndexSM (MWMFTR), which is intended to track the overall performance of attractively priced companies with sustainable competitive advantages according to Morningstar's equity research team.

  •  
      

    • Fund Ticker

      MOAT
    • Exchange

      NYSE Arca
    • Commencement

      04/24/2012
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MWMFTR
    • Index Reconstitution

      Semi-Annually, Staggered quarterly
  •  
    as of 08/21/17

    • 30-Day SEC Yield1

      1.25%
    • Total Net Assets

      $1.2B
    • Number of Holdings

      51
    • Options

      Available
    • Gross Expense Ratio2

      0.50%
    • Net Expense Ratio/TER2

      0.49%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/15/2017
  • Portfolio Composition (%)
    as of 08/21/17

    • % of Net Assets
    • Stocks

      100.01
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.01
  • Detailed Holdings Information

    Why are companies added or removed from the Index? Learn More »
  • Download All HoldingsDaily Holdings (%) as of 08/21/17

    Total Holdings: 51
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Vf Corp
    VFC US
    580,201
    36,523,6532.96
    Guidewire Software Inc
    GWRE US
    498,003
    35,472,7542.87
    Visa Inc
    V US
    334,629
    34,540,4052.80
    Gilead Sciences Inc
    GILD US
    470,188
    34,135,6492.76
    Biogen Inc
    BIIB US
    117,931
    33,392,1632.70
    Transdigm Group Inc
    TDG US
    122,772
    33,324,0042.70
    Polaris Industries Inc
    PII US
    365,543
    32,986,6002.67
    Salesforce.Com Inc
    CRM US
    357,939
    32,844,4832.66
    Bristol-Myers Squibb Co
    BMY US
    568,961
    32,225,9512.61
    Amazon.Com Inc
    AMZN US
    33,614
    32,043,8902.59
    Monsanto Co
    MON US
    270,729
    31,634,6842.56
    Amgen Inc
    AMGN US
    187,762
    31,574,0582.56
    United Technologies Corp
    UTX US
    268,094
    30,905,8762.50
    Emerson Electric Co
    EMR US
    532,662
    30,894,3962.50
    Cvs Health Corp
    CVS US
    396,629
    30,794,2762.49
    Compass Minerals International Inc
    CMP US
    465,496
    30,233,9652.45
    Express Scripts Holding Co
    ESRX US
    497,492
    30,013,6922.43
    Allergan Plc
    AGN US
    134,093
    29,898,7162.42
    Mckesson Corp
    MCK US
    202,196
    29,548,9232.39
    Eli Lilly & Co
    LLY US
    381,518
    29,521,8632.39
    Twenty-First Century Fox Inc
    FOXA US
    1,070,624
    29,302,9792.37
    Wells Fargo & Co
    WFC US
    563,812
    29,216,7382.37
    Walt Disney Co/The
    DIS US
    286,251
    28,960,0142.35
    Lowe's Cos Inc
    LOW US
    389,405
    28,757,5592.33
    Zimmer Biomet Holdings Inc
    ZBH US
    253,438
    28,580,2032.31
    Starbucks Corp
    SBUX US
    528,186
    28,073,0862.27
    Amerisourcebergen Corp
    ABC US
    347,397
    27,110,8622.20
    Stericycle Inc
    SRCL US
    376,261
    26,827,4092.17
    L Brands Inc
    LB US
    604,436
    21,934,9821.78
    Yum! Brands Inc
    YUM US
    244,637
    18,555,7161.50
    Mastercard Inc
    MA US
    138,425
    18,263,7951.48
    State Street Corp
    STT US
    196,042
    18,100,5581.47
    Cerner Corp
    CERN US
    276,030
    17,922,6281.45
    T Rowe Price Group Inc
    TROW US
    216,717
    17,850,9791.45
    Quintiles Ims Holdings Inc
    Q US
    190,488
    17,730,6231.44
    Microsoft Corp
    MSFT US
    241,105
    17,395,7261.41
    Varian Medical Systems Inc
    VAR US
    168,523
    17,057,8981.38
    Bank Of New York Mellon Corp/The
    BK US
    321,314
    16,769,3781.36
    Berkshire Hathaway Inc
    BRK/B US
    93,588
    16,690,4841.35
    Jones Lang Lasalle Inc
    JLL US
    139,764
    16,679,4361.35
    American Express Co
    AXP US
    195,241
    16,654,0571.35
    John Wiley & Sons Inc
    JW/A US
    303,740
    16,158,9681.31
    Pfizer Inc
    PFE US
    486,935
    15,951,9911.29
    Blackrock Inc
    BLK US
    37,659
    15,642,4191.27
    Ch Robinson Worldwide Inc
    CHRW US
    231,770
    15,496,1421.25
    Cbre Group Inc
    CBG US
    430,814
    15,298,2051.24
    Medtronic Plc
    MDT US
    181,229
    15,136,2461.23
    Mondelez International Inc
    MDLZ US
    333,231
    14,365,5881.16
    General Electric Co
    GE US
    562,935
    13,786,2781.12
    Patterson Cos Inc
    PDCO US
    338,296
    12,300,4431.00
    Other/Cash
    --
    --
    -173,143-0.01
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.
  • Important Disclosure

    VanEck only serves professional clients in countries where the funds are registered or where funds can be sold in accordance with local private placement rules.

    130-Day SEC Yield is a standard yield calculation developed by the Securities and Exchange Commission that allows for fairer comparisons among funds. It is based on the most recent 30-day period. This yield figure reflects the interest earned during the period after deducting the fund's expenses for the period. It does not reflect the yield an investor would have received if they had held the fund over the last twelve months assuming the most recent NAV. Distributions may vary from time to time.

    2MOAT Fees & Expenses:  Van Eck Associates Corporation (the "Adviser") has agreed to waive fees and/or pay Fund expenses to the extent necessary to prevent the operating expenses of the Fund (excluding acquired fund fees and expenses, interest expense, offering costs, trading expenses, taxes and extraordinary expenses) from exceeding 0.49% of the Fund's average daily net assets per year until at least February 1, 2018. During such time, the expense limitation is expected to continue until the Fund's Board of Trustees acts to discontinue all or a portion of such expense limitation. TER, or Total Expense Ratio, is also referred to as "Net Expense Ratio".

    3Morningstar Ratings : ©Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results. 

    4IIV is an abbreviation for the intraday indicative value of an ETF's Shares (and is also known as the Indicative Optimized Portfolio Value or IOPV), and is disseminated every 15 seconds during regular trading hours. The IIV is based on the current market value of the securities and/or cash required to be deposited in exchange for a Creation Unit. The IIV does not necessarily reflect the precise composition of the current portfolio of securities held by the Fund at a particular point in time or the best possible valuation of the current portfolio. Therefore, the IIV should not be viewed as a "real-time" update of the Fund's NAV, which is computed only once a day. The Fund is not involved in, or responsible for, the calculation or dissemination of the IIV and makes no warranty as to its accuracy.

    5According to Morningstar's proprietary valuation methodology.

    6The S&P 500® Index consists of 500 widely held common stocks covering industrial, utility, financial and transportation sector; as an Index, it is unmanaged and is not a security in which investments can be made.

    7Index performance is not indicative of Fund performance. Prior to April 24, 2012, the Fund had no operating history.

    For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a fund's monthly performance (including the effects of sales charges, loads, and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund within this scale and rated separately, which may cause slight variations in the distribution percentages.) The Overall Morningstar Rating for a fund is derived from a weighted average of the performance figures associated with its three-, five- and ten-year (if applicable) Morningstar Rating metrics.

    Prior to April 24, 2012, the Fund had no operating history. An investor cannot invest directly in an index. Returns reflect past performance and do not guarantee future results . Results reflect the reinvestment of dividends and capital gains, if any. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

    Effective June 20, 2016, Morningstar implemented several changes to the Morningstar Wide Moat Focus Index construction rules. Among other changes, the index increased its constituent count from 20 stocks to at least 40 stocks and modified its rebalance and reconstitution methodology. These changes may result in more diversified exposure, lower turnover, and longer holding periods for index constituents than under the rules in effect prior to this date. Past performance is no guarantee of future results.

    The Morningstar® Wide Moat Focus IndexSM was created and is maintained by Morningstar, Inc. Morningstar, Inc. does not sponsor, endorse, issue, sell, or promote the VanEck Vectors Wide Moat ETF and bears no liability with respect to that ETF or any security. Morningstar® is a registered trademark of Morningstar, Inc. Morningstar® Wide Moat Focus IndexSM is a service mark of Morningstar, Inc.

    The Morningstar®Wide Moat Focus IndexSMconsists of companies identified as having sustainable, competitive advantages and whose stocks are attractively priced, according to Morningstar. The S&P 500 Index consists of 500 widely held common stocks.

    An investment in the Fund may be subject to risks which include, among others, investing in the health care, consumer discretionary, industrials, information technology and financial services sectors, medium-capitalization companies, equity securities, market, operational, high portfolio turnover, index tracking, authorized participant concentration, no guarantee of active trading market, trading issues, replication management, fund shares trading, premium/discount risk and liquidity of fund shares, non-diversified, and concentration risks, which may make these investments volatile in price or difficult to trade. Medium-capitalization companies may be subject to elevated risks. The Fund's assets may be concentrated in a particular sector and may be subject to more risk than investments in a diverse group of sectors.

    Index returns are not Fund returns and do not reflect any management fees or brokerage expenses. Investors can not invest directly in the Index. Returns for actual Fund investors may differ from what is shown because of differences in timing, the amount invested and fees and expenses. Index returns assume that dividends have been reinvested.

    The S&P® 500 Index consists of 500 widely held common stocks covering industrial, utility, financial and transportation sector; as an Index, it is unmanaged and is not a security in which investments can be made.

    The "Net Asset Value" (NAV) of a VanEck Vectors Exchange Traded Fund (ETF) is determined at the close of each business day, and represents the dollar value of one share of the fund; it is calculated by taking the total assets of the fund, subtracting total liabilities, and dividing by the total number of shares outstanding. The NAV is not necessarily the same as the ETF's intraday trading value. VanEck Vectors ETF investors should not expect to buy or sell shares at NAV.

    Fund shares are not individually redeemable and will be issued and redeemed at their NAV only through certain authorized broker-dealers in large, specified blocks of shares called "creation units" and otherwise can be bought and sold only through exchange trading. Shares may trade at a premium or discount to their NAV in the secondary market. You will incur brokerage expenses when trading Fund shares in the secondary market. Past performance is no guarantee of future results. Returns for actual Fund investments may differ from what is shown because of differences in timing, the amount invested, and fees and expenses.

    Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of the Fund carefully before investing. To obtain a prospectus and summary prospectus, which contains this and other information, call 800.826.2333 or visit vaneck.com/etfs. Please read the prospectus and summary prospectus carefully before investing.

    This content is published in the United States for residents of specified countries. Investors are subject to securities and tax regulations within their applicable jurisdictions that are not addressed on this content. Nothing in this content should be considered a solicitation to buy or an offer to sell shares of any investment in any jurisdiction where the offer or solicitation would be unlawful under the securities laws of such jurisdiction, nor is it intended as investment, tax, financial, or legal advice. Investors should seek such professional advice for their particular situation and jurisdiction.